748796-38-5

Basic information

• Product Name: (6-(1H-Pyrazol-1-yl)pyridin-3-yl)methanol
• Synonyms: (6-PYRAZOL-1-YL-PYRIDIN-3-YL)-METHANOL;(6-(1H-PYRAZOL-1-YL)PYRIDIN-3-YL)METHANOL;(6-(1H-Pyrazol-1-yl)pyridin-3-yl)methanol ,97%;3-Pyridinemethanol, 6-(1H-pyrazol-1-yl)-;6-(1H-pyrazol-1-yl)-3-Pyridinemethanol;5-Hydroxymethyl-2-(1-pyrazolyl)pyridine
• CAS NO: 748796-38-5
• Molecular Formula: C9H9N3O
• Molecular Weight: 175.19
• Mol File: 748796-38-5.mol
• Article Data: 5

Chemical Properties

• Boiling Point: 361.092°C at 760 mmHg
• Flash Point: 172.183°C
• Appearance: /
• Density: 1.27g/cm³
• Vapor Pressure: 0mmHg at 25°C
• Refractive Index: 1.643
• Storage Temp.: 2-8°C
• CAS DataBase Reference: (6-(1H-Pyrazol-1-yl)pyridin-3-yl)methanol(CAS DataBase Reference)
• NIST Chemistry Reference: (6-(1H-Pyrazol-1-yl)pyridin-3-yl)methanol(748796-38-5)
• EPA Substance Registry System: (6-(1H-Pyrazol-1-yl)pyridin-3-yl)methanol(748796-38-5)

Safety Data

• Hazard Codes: N
• Statements: 51/53-36/37/38
• Safety Statements: 61-36-26
• Hazardous Substances Data: 748796-38-5(Hazardous Substances Data)

Usage

Chemical Properties

White solid

InChI:InChI=1/C9H9N3O/c13-7-8-2-3-9(10-6-8)12-5-1-4-11-12/h1-6,13H,7H2

Upstream product

• 23100-12-1 6-chloronicotinylaldehyde 
• 321533-62-4 6-(1H-pyrazol-1-yl)nicotinic acid methyl ester 
• 288-13-1 NH-pyrazole 
• 21543-49-7 2-Chloro-5-hydroxymethylpyridine 

Downstream Products

• 748796-39-6 5-(chloromethyl)-2-(1H-pyrazol-1-yl)pyridine 

Relevant articles and documents

NITROGEN-CONTAINING HETEROCYCLIC COMPOUND

The present invention provides a compound having a cholinergic muscarinic M1 receptor positive allosteric modulator activity and useful as a medicament such as a prophylactic or therapeutic drug for Alzheimer's disease, schizophrenia, pain, sleep disorder, Parkinson's disease dementia, dementia with Lewy bodies and the like, and the like. The present invention relates to a compound represented by the formula (I) or a salt thereof. wherein each symbol is as described in the attached DESCRIPTION.

Processes for the preparation of O-(6-pyrazol-1-yl-pyridin-3-ylmethyl)-hydroxylamine

The present invention relates generally to novel methods for the synthesis of O-(6-pyrazol-1-yl-pyridin-3-ylmethyl)-hydroxylamine which is an essential reagent in the synthesis of one of the bridged erythromycin derivatives and their respective pharmaceutically acceptable salts in PCT Application WO 03/097659 A1. In particular, the present invention relates to processes and intermediates for the preparation of a compound of formula (Ia):

Processes for the preparation of 6-11 bicyclic erythromycin derivatives

The present invention relates to processes and intermediates for the preparation of 6-11 bicyclic erythromycin derivatives. In particular, the present invention relates to processes and intermediates for the preparation of a compound of formula (IX-c):